Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page.

“We have always understood that women are the most influential customer in the health space, both because they have the most health needs and are decision-makers for health in the household and unlock the rest of the population.” Kasha Founder & CEO Joanna Bichsel

This Week’s Highlights

Kasha adds $21M in Series B funding to scale its women’s health platform in Africa.

Family First secures $11M in Series A funding for its caregiver support platform.

Berlin-based Hale raises €350K to transform women’s pelvic pain management.

Eureka Health raises $7M in seed funding to connect chronically ill patients.

Emagine secures $1M from the U.S. National Science Foundation to advance its suite of maternal health tools.

Wisdom Ventures closes $10M Fund I to champion human connection and well-being.

Israeli medtech company InModeacquires IP assets from Viveve to strengthen its position in the women’s health space.

New study by Gennev reveals 47% higher healthcare expenses for women in menopause.

New study: Zai Lab‘s ZEJULA maintenance therapy shows promising results in advanced Ovarian Cancer patients.

New study validates Ziwig‘s saliva-based Endotest as effective alternative to surgical diagnosis for endometriosis.

SKYLARK Trial unveils promising oral therapy for postpartum depression.

This week’s newsletter is powered by Femovate:

🚀 Ignite your Femtech innovation with product & design expertise from Guidea. Apply for sponsorship from the transformative UX design program, Femovate.

Led by award-winning UX experts at Guidea, Femovate helps Femtech innovators create and refine engaging tools that improve lives through tailored UX research, strategy, and design guidance. Explore your customers’ journey, identify what sets you apart, and design intuitive and effective digital health solutions.

Femovate is the springboard to successful funding, commercialization and global health impact you’ve been looking for.

See if your early stage femtech company is eligible for sponsorship at www.femovate.com and apply by Sep 18, 2023.

In the Know

IVF Access: Today’s Challenges and Tomorrow’s Innovations (Femtech Insider)

The Misrepresentation of Women’s Health in Stock Imagery: A Call for Change (Femtech Insider)

From Sexologist to Startup Founder: How Rebecca Alvarez Story‘s Pioneering Work Helped Create the Sexual Wellness Category (Femtech Insider)

‘There is no standard’: investigation finds AI algorithms objectify women’s bodies (Guardian)

Organon finally offers a larger pharma model for women’s health. But ‘one company can’t do it by itself’ (Fierce Biotech)

It’s Time For a Billion-Dollar Women’s Health Fund (In Vivo)

Male Fertility Crisis? (Valet)

Why Women’s Health Is Key to Healthy Economies (Gates Foundation)

Show CommentsClose Comments

Leave a comment